Tuesday, August 17, 2021: Neuberg Diagnostics, India’s fourth-largest diagnostic lab chain, today announced that it has partnered with ace cricketer, MS Dhoni, for creating awareness about Neuberg’s health and wellness campaign and conveying its efforts towards empowering every citizen with better and affordable healthcare.
Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics, said, “MS Dhoni complements our growth mindset, and thus is a strategic fit during our growth years. We are excited about this association and are honored to have him on board as our evangelist and global brand ambassador. We are keen to take our plethora of diagnostic services across the country and convey our efforts towards empowering every citizen with better and affordable healthcare. Furthermore, Dhoni’s commitment towards maintaining good health and fitness resonates well with our mission and will remind people to prioritize their health. Dhoni’s backing will enable us to communicate about our commitment and services more effectively.”
MS Dhoni, Former India Skipper and Captain of Chennai Super Kings, said, “The leaders at Neuberg are committed to providing affordable healthcare across India, and that really struck me and it’s a pleasure to be associated with the team and their various programs aimed at providing access to quality and affordable healthcare. Amidst the Covid-19 pandemic, they have taken up the campaign to raise awareness about health and wellness across age groups. I personally feel that these efforts are important and deserve to be advocated.”
On the back of growing footprints, the company has been seeing robust growth. In a matter of four years since its inception, with a presence in three continents, the company ended its FY21 with revenues of Rs.800 crore, and on the back of its differentiated offerings, it is aiming to close FY22 with revenues of Rs.1000 crore with more than 200 labs and 3000 collection centers, located across the world.
MS Dhoni will also enable the company to generate recall across its global markets in the UAE, South Africa and the USA.
About Neuberg Diagnostics:
The best-in-class laboratories across India, the UAE, South Africa and the USA have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, Neuberg Diagnostics brings capabilities to perform over 6000 varieties of pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs, and Structured Disease Management programs for rare diseases using the most advanced technologies, assisted by data science and AI tools.
Since its inception, besides starting greenfield labs, it had also acquired Anand Diagnostic Laboratory in Bengaluru, Supratech Micropath Laboratory in Ahmedabad, Ehrlich Laboratory in Chennai, and A.G. Diagnostics Laboratory in Pune, to expand its presence across India. In addition, it has also acquired Global Labs in South Africa and Minerva Diagnostics in Dubai, to expand its footprint in the global arena.
With 14 approved labs for COVID-19 testing in India, it has the capability to process more than 65,000 COVID samples in a day.
Some of the best Pathologists, Biochemists, Geneticists, Microbiologists, and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge, and using the latest generation of diagnostic techniques to take accurate and timely diagnosis to the next level.
Currently, Neuberg Diagnostics has over 120 labs and 1000 touch points across 4 countries. Neuberg Diagnostics also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services and Drive-through Phlebotomy Services.